Northern Trust’s Eledon Pharmaceuticals ELDN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.23M Buy
454,077
+323,404
+247% +$876K ﹤0.01% 3272
2025
Q1
$443K Buy
130,673
+3,788
+3% +$12.8K ﹤0.01% 3625
2024
Q4
$523K Buy
126,885
+34,992
+38% +$144K ﹤0.01% 3642
2024
Q3
$229K Hold
91,893
﹤0.01% 3838
2024
Q2
$243K Buy
91,893
+52,089
+131% +$138K ﹤0.01% 3794
2024
Q1
$82K Sell
39,804
-96
-0.2% -$198 ﹤0.01% 4130
2023
Q4
$71.8K Sell
39,900
-7,528
-16% -$13.6K ﹤0.01% 4170
2023
Q3
$65K Buy
47,428
+17,375
+58% +$23.8K ﹤0.01% 4107
2023
Q2
$41.2K Hold
30,053
﹤0.01% 4263
2023
Q1
$70.9K Hold
30,053
﹤0.01% 4172
2022
Q4
$68.5K Hold
30,053
﹤0.01% 4203
2022
Q3
$83K Hold
30,053
﹤0.01% 4174
2022
Q2
$73K Hold
30,053
﹤0.01% 4289
2022
Q1
$118K Hold
30,053
﹤0.01% 4296
2021
Q4
$133K Hold
30,053
﹤0.01% 4333
2021
Q3
$186K Sell
30,053
-2,063
-6% -$12.8K ﹤0.01% 4212
2021
Q2
$254K Buy
32,116
+16,588
+107% +$131K ﹤0.01% 4047
2021
Q1
$166K Buy
+15,528
New +$166K ﹤0.01% 4157
2020
Q4
Sell
-1,294
Closed -$22K 4386
2020
Q3
$22K Buy
1,294
+654
+102% +$11.1K ﹤0.01% 4201
2020
Q2
$5K Buy
+640
New +$5K ﹤0.01% 4233
2017
Q2
Sell
-649
Closed -$87K 4281
2017
Q1
$87K Sell
649
-7
-1% -$938 ﹤0.01% 3985
2016
Q4
$104K Buy
656
+5
+0.8% +$793 ﹤0.01% 3891
2016
Q3
$161K Sell
651
-139
-18% -$34.4K ﹤0.01% 3792
2016
Q2
$705K Buy
790
+59
+8% +$52.7K ﹤0.01% 3433
2016
Q1
$664K Sell
731
-1
-0.1% -$908 ﹤0.01% 3385
2015
Q4
$1.03M Buy
732
+156
+27% +$220K ﹤0.01% 3307
2015
Q3
$966K Buy
576
+172
+43% +$288K ﹤0.01% 3326
2015
Q2
$871K Buy
404
+8
+2% +$17.2K ﹤0.01% 3394
2015
Q1
$725K Buy
396
+50
+14% +$91.5K ﹤0.01% 3502
2014
Q4
$825K Buy
+346
New +$825K ﹤0.01% 3443